Bariederm Cream in Chronic Contact Dermatitis

Status Not yet recruiting

Clinical Trial Summary

We intend to evaluate the efficiency and tolerability of a barrier cream (bariederm) in protecting hands of individuals with hand dermatitis, either due to allergy or irritation. We believe that the use of the cream would benefit with the skin.

Clinical Trial Description

The aim of the study is the evaluation of the effectiveness, tolerance and cosmetic acceptability of Bariéderm cream among patients presenting with chronic allergic or irritant contact dermatitis of the hands. We shall enrol adults presenting with CONTACT DERMATITIS EXCLUDING FLARE-UPS of the hands: whether allergic or irritant, able to understand the protocol and agrees to sign the information and informed consent form. Bariéderm cream will be applied minimum twice daily over 21 days. Response will be evaluated by self and physician filled questionnaires. effectiveness, tolerance and cosmetic acceptability will be evaluated by a scale of 1-10, 1 meaning "not at all" and 10 meaning "very much". Statistics will be performed by SPSS software with suitable statistical tests. In case of an adverse event caused by the product, patch-test with ingredients of Bariéderm cream will be performed. ;

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02026700
Study type	Interventional
Source	Hadassah Medical Organization
Contact	liran horev, md
Phone	00972508573992
Email	rlirano@hadassah.org.il
Status	Not yet recruiting
Phase	N/A
Start date	February 2014
Completion date	March 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00371163` - Molecular and Cellular Characterization of Spongiotic Dermatitis	N/A
Completed	`NCT02028208` - Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study	Phase 2
Not yet recruiting	`NCT04853823` - A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB	Phase 1
Recruiting	`NCT06387472` - DermAI to Evaluate Human Factor of Testing	N/A
Completed	`NCT02700373` - A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers	Phase 1
Completed	`NCT03089775` - Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis	Phase 1
Completed	`NCT04438135` - Children With Aluminium Contact Allergy: Cutaneous Exposure Study	N/A
Recruiting	`NCT06189144` - Testing an Intervention in Irritative Contact Dermatitis	N/A
Completed	`NCT04921163` - Children With Aluminium Contact Allergy: Oral Exposure Study	N/A
Completed	`NCT02028182` - Clinical Evaluation of Lyral® Dose Response Study	Phase 2
Completed	`NCT00824889` - Exploratory Study of Natural Killer Cells in Human Skin	N/A
Completed	`NCT00646867` - Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis	N/A
Withdrawn	`NCT01518348` - Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents	Phase 3
Recruiting	`NCT03705182` - Prevention of Dermatitis in Epoxy Exposed Workers	N/A
Terminated	`NCT03198390` - Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
Completed	`NCT00614289` - Novel Topical Treatment of Hand Dermatitis (Eczema)	Phase 1
Recruiting	`NCT06331390` - Assessment of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis	N/A
Completed	`NCT00640250` - Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response	Phase 2
Completed	`NCT00640614` - Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy	Phase 3
Recruiting	`NCT06177314` - Molecular Diagnosis of Allergic Contact Dermatitis